Israel Englander Rapt Therapeutics, Inc. Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$2.89 - $9.38 $346,800 - $1.13 Million	120,000 Added 400.0%	150,000 $457,000
Q1 2024 May 15, 2024	BUY	$6.87 - $26.45 $68,700 - $264,500	10,000 Added 50.0%	30,000 $269,000
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $225,600 - $509,200	20,000 New	20,000 $497,000
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $343,800 - $616,000	20,000 New	20,000 $367,000
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $898,000 - $1.52 Million	50,000 New	50,000 $1.2 Million

125

29.1M

905K

592K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $53.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.